121 related articles for article (PubMed ID: 23518709)
1. Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
Morsali D; Bechtold D; Lee W; Chauhdry S; Palchaudhuri U; Hassoon P; Snell DM; Malpass K; Piers T; Pocock J; Roach A; Smith KJ
Brain; 2013 Apr; 136(Pt 4):1067-82. PubMed ID: 23518709
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis.
Guadalupi L; Vanni V; Balletta S; Caioli S; De Vito F; Fresegna D; Sanna K; Nencini M; Donninelli G; Volpe E; Mariani F; Battistini L; Stampanoni Bassi M; Gilio L; Bruno A; Dolcetti E; Buttari F; Mandolesi G; Centonze D; Musella A
J Neuroinflammation; 2024 May; 21(1):128. PubMed ID: 38745307
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of Sinomenine on Experimental Autoimmune Encephalomyelitis via Anti-Inflammatory and Nrf2-Dependent Anti-Oxidative Stress Activity.
Fan H; Yang Y; Bai Q; Wang D; Shi X; Zhang L; Yang Y
Neuromolecular Med; 2023 Dec; 25(4):545-562. PubMed ID: 37735290
[TBL] [Abstract][Full Text] [Related]
4. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
Marik C; Felts PA; Bauer J; Lassmann H; Smith KJ
Brain; 2007 Nov; 130(Pt 11):2800-15. PubMed ID: 17956913
[TBL] [Abstract][Full Text] [Related]
5. Fluorinated apelin-13 mediates neuroprotective effects in multiple sclerosis models.
Birmpili D; Charmarké-Askar I; Spenlé C; Riché S; Pham-Van LD; Kuntzel T; Xhurxhi T; Riou A; Bonnet D; Bagnard D
Neurobiol Dis; 2024 Aug; 198():106552. PubMed ID: 38844244
[TBL] [Abstract][Full Text] [Related]
6. Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis.
Schampel A; Volovitch O; Koeniger T; Scholz CJ; Jörg S; Linker RA; Wischmeyer E; Wunsch M; Hell JW; Ergün S; Kuerten S
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3295-E3304. PubMed ID: 28381594
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of Zinc in the Pathogenesis of Multiple Sclerosis.
Choi BY; Jung JW; Suh SW
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28956834
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV inhibits experimental autoimmune encephalomyelitis by modulating the polarization of both microglia/macrophages and astrocytes.
Yu J; Mu B; Guo M; Liu C; Meng T; Yan Y; Song L; Yu J; Kumar G; Ma C
Folia Neuropathol; 2023; 61(3):273-290. PubMed ID: 37818688
[TBL] [Abstract][Full Text] [Related]
9. Induction of IL-2 by interleukin-12 p40 homodimer and IL-12, but not IL-23, in microglia and macrophages: Implications for multiple sclerosis.
Jana M; Mondal S; Jana A; Pahan K
Cytokine; 2024 Feb; 174():156457. PubMed ID: 38056248
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells as therapeutic targets in neuroinflammation.
Luessi F; Zipp F; Witsch E
Cell Mol Life Sci; 2016 Jul; 73(13):2425-50. PubMed ID: 26970979
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of blocking GAPDH nitrosylation with CGP3466b in experimental autoimmune encephalomyelitis.
Godfrey WH; Hwang S; Cho K; Shanmukha S; Gharibani P; Abramson E; Kornberg MD
Front Neurol; 2022; 13():979659. PubMed ID: 36761918
[TBL] [Abstract][Full Text] [Related]
12. Extra-axonal restricted diffusion as an in-vivo marker of reactive microglia.
Taquet M; Jankovski A; Rensonnet G; Jacobs D; des Rieux A; Macq B; Warfield SK; Scherrer B
Sci Rep; 2019 Sep; 9(1):13874. PubMed ID: 31554896
[TBL] [Abstract][Full Text] [Related]
13. Juxtacortical Paramagnetic Rim: A New MRI Marker to Characterize Focal Cortical Pathology in Multiple Sclerosis?
Rocca MA; Preziosa P; Filippi M
Neurology; 2024 Feb; 102(3):e208085. PubMed ID: 38165304
[TBL] [Abstract][Full Text] [Related]
14. Bushen Yisui Capsule ameliorates axonal injury in experimental autoimmune encephalomyelitis.
Fang L; Zheng Q; Yang T; Zhao H; Zhang Q; Li K; Zhou L; Gong H; Fan Y; Wang L
Neural Regen Res; 2013 Dec; 8(35):3306-15. PubMed ID: 25206652
[TBL] [Abstract][Full Text] [Related]
15. Should mast cells be considered therapeutic targets in multiple sclerosis?
Pinke KH; Zorzella-Pezavento SFG; Lara VS; Sartori A
Neural Regen Res; 2020 Nov; 15(11):1995-2007. PubMed ID: 32394947
[TBL] [Abstract][Full Text] [Related]
16. The microglial hypothesis of multiple sclerosis.
Hautecoeur P; Kwiatkowski A; Drouin E
Lancet Neurol; 2023 Aug; 22(8):655. PubMed ID: 37479369
[No Abstract] [Full Text] [Related]
17. Natural killer cells that target autoimmune cells linked with protection against multiple sclerosis.
Bordon Y
Nat Rev Immunol; 2024 Feb; 24(2):88. PubMed ID: 38195992
[No Abstract] [Full Text] [Related]
18. 1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.
Chung JY; Lee JW; Ryu CH; Min HK; Yoon YJ; Lim MJ; Park CH
J Neurosci Res; 2015 Aug; 93(8):1267-78. PubMed ID: 25711470
[TBL] [Abstract][Full Text] [Related]
19. Nav1.6 promotes inflammation and neuronal degeneration in a mouse model of multiple sclerosis.
Alrashdi B; Dawod B; Schampel A; Tacke S; Kuerten S; Marshall JS; Côté PD
J Neuroinflammation; 2019 Nov; 16(1):215. PubMed ID: 31722722
[TBL] [Abstract][Full Text] [Related]
20. D
Savva K; Zachariou M; Bourdakou MM; Dietis N; Spyrou GM
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
